P3.02a-036 Phase 1 Study of Ceritinib 450 mg or 600 mg Taken with a Low-Fat Meal versus 750 mg in Fasted State in ALK+ Metastatic NSCLC Rafal Dziadziuszko,

Slides:

Advertisements

Similar presentations

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic.

Advertisements

SC17.02 Lung Cancer in China: Challenges and Perspectives

Journal of Thoracic Oncology Volume 11, Issue 4, Pages (April 2016)

PL03.07: First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4) Gilberto De Castro,

P3.02a-025 PROs With Ceritinib Versus Chemotherapy in Patients With Previously Untreated ALK-rearranged Nonsquamous NSCLC (ASCEND-4) Daniel Shao-Weng.

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non–Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib.

P3.02b-001 Phase 1 Dose Escalation of PF (EGFR-T790M Inhibitor) in Patients with Advanced EGFRm (Del 19 or L858R+/-T790M) NSCLC Hatim Husain,

P Comparison of Peri-Operative Outcomes after Robotic-Assisted Video- Thoracoscopic Lobectomies versus Segmentectomies Maria Echavarria, Anna.

Journal of Thoracic Oncology Volume 12, Issue 3, Pages (March 2017)

MA12.06 Tumor Spread through Air Spaces (STAS) in Lung Squamous Cell Cancer is an Independent Risk Factor: A Competing Risk Analysis Shaohua Lu, Takashi.

MA12.09 Comparative Histological Subtype Analysis of Lung Adenocarcinoma Tumor and Metastatic Lymph Nodes and the Prognostic Impact Shaohua Lu, Takashi.

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

P Transcriptional Profiling Identified the Anti-Proliferative Effect of Mitofusin-2 Deficiency and Its Risk in Lung Adenocarcinoma Yuqing Lou,

P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC) Nicholas Faris, Meredith.

OA20.03 Tumoral IL-7 Receptor is a Potential Target for Lung Adenocarcinoma Immunotherapy Ming-Ching Lee, Takashi Eguchi, Zachary Tano, Kyuichi Kadota,

P Typical Morphological Features Revealed Unfavorable Survival Benefits in High-Grade Neuroendocrine Carcinomas Hao-Ran Zhai, Jia-Tao Zhang,

PUB023 Effectiveness of Three-Dimensional Video System in Single Port Thorascopic Major Pulmonary Resection: Propensity Score Matched Analysis Hyun Koo.

P Pleural CEA and C-Reactive Protein in Patients with Lung Metastases and Malignant Pleural Effusion. A Prospective Case-Control Study Franco.

Journal of Thoracic Oncology Volume 12, Issue 5, Pages (May 2017)

Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green

Journal of Thoracic Oncology Volume 13, Issue 2, Pages (February 2018)

P SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial Yenting Ngai,

P3.02b-075 Addition of Bevacizumab for Malignant Pleural Effusion as the Manifestation of Acquired EGFR-TKI Resistance in NSCLC Patients Tao Jiang, Shengxiang.

LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD- 1/PD-L1 and Tumor-Infiltrating Lymphocytes Yayi He, MD, PhD, Hui.

P3.02a-012 Patient-Reported Symptoms and Quality of Life (QoL) in East Asian Patients with ALK+ NSCLC Treated with Crizotinib vs Chemotherapy You Lu,

Journal of Thoracic Oncology Volume 11, Issue 2, Pages (February 2016)

Support Your Specialty

P1.22: Temporal Survival Improvement for Stage-II (T3N0M0) Lung Adenocarcinoma After Pulmonary Lobectomy Danny T. Nguyen, Jacques-Pierre Fontaine, Lary.

Journal of Thoracic Oncology Volume 12, Issue 7, Pages (July 2017)

Erratum The American Journal of Human Genetics

Journal of Thoracic Oncology Volume 12, Issue 8, Pages (August 2017)

ED11.01 Systemic Therapy for Advanced Oncogene-Driven NSCLC

P3.02b-061 A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non- Small Cell Lung Cancer (NSCLC) with EGFR Mutations Christina Baik,

JCSE01.16 Positive Correlation Between Whole Genomic Copy Number Variant Scoring and the Grading System in Lung Non-Mucinous Invasive Adenocarcinoma

Journal of Thoracic Oncology Volume 11, Issue 10, Pages (October 2016)

Journal of Thoracic Oncology Volume 12, Issue 10, Pages (October 2017)

P Comparison of Pulmonary Function after Robotic-Assisted Video- Thoracoscopic Lobectomies vs Segmentectomies Maria Echavarria, Anna Cheng, Frank.

Journal of Thoracic Oncology Volume 11, Issue 5, Pages (May 2016)

Journal of Thoracic Oncology Volume 11, Issue 8, Pages (August 2016)

Table of contents The Journal for Nurse Practitioners

Journal of Thoracic Oncology

P3.02b-017 Sequence of EGFR-TKI Therapy and BIM Deletion Polymorphism Affect the Outcome of Treatment in EGFR Positive NSCLC Chanchai Charonpongsuntorn,

P3.02a-023 Treatment Patterns and Early Outcomes of ALK+ Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study Edmond Bendaly,

M. Kusumoto Journal of Thoracic Oncology

OA07.06 In Early-Stage Lung Adenocarcinomas, Survival by Tumor Size (T) is Further Stratified by Tumor Spread through Air Spaces Takashi Eguchi, Koji.

P Differentially Expressed microRNAs in Lung Adenocarcinoma Invert Effects of Copy Number Aberrations of Prognostic Genes Tomas Tokar, Emily.

In This Issue Journal of Thoracic Oncology

Table of Contents Journal of Thoracic Oncology

MA12.05 Can Tumor Spread through Air Spaces (STAS) in Lung Adenocarcinomas Be Predicted Pre- and Intraoperatively? Koji Kameda, Shaohua Lu, Takashi Eguchi,

Journal of Thoracic Oncology Volume 13, Issue 3, Pages (March 2018)

P Clinical Significance of Preoperative Neutrophil-Lymphocyte Ratio in Patients with Thymic Epithelial Tumor Undergoing Surgery S. Okada, S.

European Lung Cancer Conference (ELCC) 2016 Organisation

P Implications of 8th Edition TNM Proposal: Invasive vs

OA Video-Assisted Thoracoscopic Surgery vs

MA02.10 The First Year of Implementing a Lung Cancer Screening Program in an Urban Safety-Net Health System H. Hamann, S. Lee, T. Browning, C. Chavez,

P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment

Validity of International Association for the Study of Lung Cancer Proposals for the Revision of N Descriptors in Lung Cancer Jin Gu Lee, MD, Chang Young.

PUB001 Advanced NSCLC Patients at the Extremes of Age in the Era of EGFR-TKIs Yu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, Tung-Ying Chao, Chia-Cheng.

P Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI Y. Zhang, Q. Zhou,

Journal of Thoracic Oncology Volume 13, Issue 6, Pages (June 2018)

The Journal of Thoracic and Cardiovascular Surgery

Journal of Thoracic Oncology

P Post-Recurrence Survival Analysis of Stage I Non-Small Cell Lung Cancer: Prognostic Significance of Local Treatment Kanghoon Lee, Hyeong Ryul.

P1. 02: Lung Cancer - A Previously Years Survival Study

PUB019 Preoperative Needle Biopsy and Tumor Spread through Alveolar Spaces (STAS) in Resected Lung Adenocarcinomas Koji Kameda, Takashi Eguchi, Shaohua.

Mark A. Socinski, MD Journal of Thoracic Oncology

Y. Lou, R. Manochakian, J. Cochuyt, D. Hodge, S. Ailawadhi

Robert Comis, MD, The Passing of a “Lung Man”

ED04.01 Surgery in Bronchopulmonary Typical and Atypical Carcinoids

Presentation transcript:

P3.02a-036 Phase 1 Study of Ceritinib 450 mg or 600 mg Taken with a Low-Fat Meal versus 750 mg in Fasted State in ALK+ Metastatic NSCLC Rafal Dziadziuszko, Dong-Wan Kim, Alessandra Bearz, Scott Laurie, Mark Mckeage, Keunchil Park, Sang-We Kim, Vanessa Q. Passos, Karen Osborne, Yvonne Y. Lau, Jessie Gu, Byoung Chul Cho Journal of Thoracic Oncology Volume 12, Issue 1, (January 2017) DOI: 10.1016/j.jtho.2016.11.1666 Copyright © 2016 Terms and Conditions

Journal of Thoracic Oncology 2017 12, DOI: (10. 1016/j. jtho. 2016. 11 Copyright © 2016 Terms and Conditions